---
figid: PMC6183029__NRR-13-1927-g009
figtitle: The signal transduction pathway activated by PND in PC12 cells.The proposed
  PND-activated cAMP-Epac1-Erk-CREB pathway is shown in the red arrow-connected cascade
organisms:
- Armoracia rusticana
- Panax ginseng
- Daucus carota
- Panax notoginseng
- Bos taurus
- Equus caballus
- Homo sapiens
- Rattus norvegicus
pmcid: PMC6183029
filename: NRR-13-1927-g009.jpg
figlink: /pmc/articles/PMC6183029/figure/F7/
number: F7
caption: 'Schematic representation of the signal transduction pathway activated by
  PND in PC12 cells.The proposed PND-activated cAMP-Epac1-Erk-CREB pathway is shown
  in the red arrow-connected cascade. It remains unknown if PND directly activates
  PACAP receptor or adenylyl cyclase (shown in dash arrows). Rap1 and B-Raf were not
  examined in this study and so are shown in dashed arrows. NGF binds to Trk receptors
  that activate a downstream Erk1/2 pathway to induce neurite outgrowth. Forskolin
  directly activates adenylyl cyclase to induce PKA-dependent Erk1/2 phosphorylation.
  SU5416: Trk inhibitor; SQ22536: adenylyl cyclase inhibitor; Rp-cAMPS: cAMP analog;
  H89: PKA inhibitor; U0126: MAP kinase inhibitor. PND: Panaxydol; cAMP: cyclic adenosine
  3′,5′-monophosphate; CREB: cAMP response element binding protein; Epac1: exchange
  protein directly activated by cAMP 1; Erk: extracellular signal-regulated kinase;
  MAPK: mitogen-activated protein kinase; PACAP: pituitary adenylate cyclase-activating
  polypeptide; PKA: protein kinase A; NGF: nerve growth factor.'
papertitle: Molecular mechanism of panaxydol on promoting axonal growth in PC12 cells.
reftext: Wei-Peng Li, et al. Neural Regen Res. 2018 Nov;13(11):1927-1936.
year: '2018'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9614349
figid_alias: PMC6183029__F7
figtype: Figure
organisms_ner:
- Rattus norvegicus
- Bos taurus
- Equus caballus
- Homo sapiens
redirect_from: /figures/PMC6183029__F7
ndex: e2cf45d2-dedb-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6183029__NRR-13-1927-g009.html
  '@type': Dataset
  description: 'Schematic representation of the signal transduction pathway activated
    by PND in PC12 cells.The proposed PND-activated cAMP-Epac1-Erk-CREB pathway is
    shown in the red arrow-connected cascade. It remains unknown if PND directly activates
    PACAP receptor or adenylyl cyclase (shown in dash arrows). Rap1 and B-Raf were
    not examined in this study and so are shown in dashed arrows. NGF binds to Trk
    receptors that activate a downstream Erk1/2 pathway to induce neurite outgrowth.
    Forskolin directly activates adenylyl cyclase to induce PKA-dependent Erk1/2 phosphorylation.
    SU5416: Trk inhibitor; SQ22536: adenylyl cyclase inhibitor; Rp-cAMPS: cAMP analog;
    H89: PKA inhibitor; U0126: MAP kinase inhibitor. PND: Panaxydol; cAMP: cyclic
    adenosine 3′,5′-monophosphate; CREB: cAMP response element binding protein; Epac1:
    exchange protein directly activated by cAMP 1; Erk: extracellular signal-regulated
    kinase; MAPK: mitogen-activated protein kinase; PACAP: pituitary adenylate cyclase-activating
    polypeptide; PKA: protein kinase A; NGF: nerve growth factor.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Ngf
  - Adcyap1
  - Mzb1
  - Ntrk1
  - Braf
  - Map2k1
  - Mapk3
  - Mapk1
  - Creb1
  - Atf1
  - Tmprss5
  - NGF
  - MZB1
  - ADCYAP1
  - RAF1
  - BRAF
  - MAPK3
  - MAPK1
  - CREB1
  - ATF1
  - GZMB
  - NTRK1
  - TPM3
  - XYLT2
  - SOS1
  - SOS2
  - KRAS
  - HRAS
  - NRAS
  - ATP8A2
  - RAPGEF3
  - RAP1A
  - RABGEF1
  - TERF2IP
  - RAP1B
  - PRKAR1A
  - PRKAR1B
  - PRKAR2A
  - PRKAR2B
  - PRKACA
  - PRKACB
  - PRKACG
  - MAP2K1
  - MAP2K2
  - CREB3
  - CREB5
  - CREB3L1
  - CREB3L2
  - CREB3L3
  - CREB3L4
  - CREM
  - ATF2
  - GDNF
  - APRT
  - MFAP1
  - forskolin
  - panaxydol
  - Adenylyl
  - SQ22536
  - ATP
  - Cancer
  - Cardiomyopathy
  - Noonan syndrome
---
